Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 4 | 2016 | 6944 | 0.130 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2013 | 197 | 0.100 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2013 | 169 | 0.100 |
Why?
|
| Chemokine CXCL10 | 1 | 2013 | 310 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2008 | 1237 | 0.100 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2016 | 923 | 0.100 |
Why?
|
| Tartrates | 1 | 2007 | 13 | 0.070 |
Why?
|
| Atenolol | 1 | 2007 | 99 | 0.070 |
Why?
|
| Metoprolol | 1 | 2007 | 89 | 0.070 |
Why?
|
| HIV Infections | 4 | 2016 | 17533 | 0.070 |
Why?
|
| Propanolamines | 1 | 2007 | 163 | 0.070 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 248 | 0.070 |
Why?
|
| Carbazoles | 1 | 2007 | 229 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2008 | 608 | 0.050 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2008 | 521 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 2210 | 0.050 |
Why?
|
| Cardiovascular Agents | 1 | 2008 | 851 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 3211 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 4405 | 0.040 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 2033 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2008 | 2334 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2008 | 2692 | 0.040 |
Why?
|
| Lipids | 1 | 2008 | 3315 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2007 | 2897 | 0.030 |
Why?
|
| Health Maintenance Organizations | 2 | 2008 | 656 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2007 | 3714 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2007 | 2975 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2007 | 3286 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2016 | 670 | 0.020 |
Why?
|
| Mass Screening | 1 | 2008 | 5446 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2016 | 878 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2008 | 4736 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 2012 | 5501 | 0.020 |
Why?
|
| Granzymes | 1 | 2012 | 278 | 0.020 |
Why?
|
| Germany | 1 | 2012 | 882 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5891 | 0.020 |
Why?
|
| Proportional Hazards Models | 3 | 2008 | 12509 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2012 | 1347 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2012 | 1336 | 0.020 |
Why?
|
| Postal Service | 1 | 2008 | 96 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2016 | 1889 | 0.020 |
Why?
|
| Teratogens | 1 | 2008 | 121 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2013 | 18973 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 11499 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6069 | 0.020 |
Why?
|
| Aluminum | 1 | 2007 | 150 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2012 | 2587 | 0.020 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 429 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3564 | 0.010 |
Why?
|
| Monocytes | 1 | 2013 | 2595 | 0.010 |
Why?
|
| Virus Replication | 1 | 2012 | 2447 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2012 | 3160 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2012 | 2864 | 0.010 |
Why?
|
| California | 1 | 2007 | 1436 | 0.010 |
Why?
|
| Heart Failure | 1 | 2007 | 11840 | 0.010 |
Why?
|
| Viral Load | 1 | 2012 | 3386 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2013 | 2747 | 0.010 |
Why?
|
| Databases, Factual | 2 | 2008 | 8067 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2007 | 2910 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6499 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 1514 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2016 | 6610 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 4528 | 0.010 |
Why?
|
| Outpatients | 1 | 2008 | 1595 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2007 | 1160 | 0.010 |
Why?
|
| United States | 4 | 2008 | 72903 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 4850 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9338 | 0.010 |
Why?
|
| Male | 6 | 2016 | 363698 | 0.010 |
Why?
|
| Female | 7 | 2013 | 396112 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40065 | 0.010 |
Why?
|
| Humans | 9 | 2016 | 765968 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 9525 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6309 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2012 | 9347 | 0.010 |
Why?
|
| Macrophages | 1 | 2012 | 5772 | 0.010 |
Why?
|
| Middle Aged | 5 | 2008 | 223009 | 0.010 |
Why?
|
| Adult | 5 | 2008 | 223044 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2012 | 10429 | 0.010 |
Why?
|
| Pregnancy | 2 | 2008 | 30260 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 14751 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13632 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2008 | 81514 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16721 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3251 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29922 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 15842 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 23601 | 0.010 |
Why?
|
| Adolescent | 2 | 2008 | 88835 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2007 | 26346 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 39193 | 0.000 |
Why?
|
| Obesity | 1 | 2008 | 13076 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2008 | 41649 | 0.000 |
Why?
|
| Aged | 2 | 2008 | 171117 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 59489 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2007 | 65188 | 0.000 |
Why?
|
| Risk Factors | 1 | 2007 | 74840 | 0.000 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_